Израиль - иврит - Ministry of Health

pharma medis - fentanyl as citrate - תמיסה להזרקה - fentanyl as citrate 0.05 mg/ml - fentanyl - fentanyl - for analgesic action of short duration during anesthtic periods (premedication dinduction and maintenance) and in the immediate postoperative period as need arises. as a narcotic analgesic supplement in general or regional anesthesia. for administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. for use as an anesthetic agent with oxygen in selected high-risk patients (open heart surgery or certain neurological or orthopedic procedures). by the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthesia.

Израиль - иврит - Ministry of Health

taro pharmaceutical industries ltd - fentanyl as citrate 0.05 mg/ml - solution for injection - fentanyl - for analgesic action of short duration during anesthetic periods (premedication, induction and maintenance) and in the immediate postoperative period, as need arises. as a narcotic analgesic supplement in general or regional anesthesia. for administration with neuroleptics as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. for use as an anesthetic agent with oxygen in selected, high-risk patients (open heart surgery or certain neurological or ortopedic procedures). by the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthsia.

Израиль - иврит - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - תמיסה להזרקה - fentanyl as citrate 0.05 mg/ml - fentanyl - fentanyl - for analgesic action of short duration during anesthtic periods (premedication dinduction and maintenance) and in the immediate postoperative period as need arises. as a narcotic analgesic supplement in general or regional anesthesia. for administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. for use as an anesthetic agent with oxygen in selected high-risk patients (open heart surgery or certain neurological or orthopedic procedures). by the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthesia.

Израиль - иврит - Ministry of Health

trima israel pharmaceutical products maabarot ltd - lamotrigine - טבליה - lamotrigine 25 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seiaures. primary generalised tonic clonic seizures. add- on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. primary generalised tonic clonic seizures. adults ( 18 years of age and over) : lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Израиль - иврит - Ministry of Health

trima israel pharmaceutical products maabarot ltd - lamotrigine - טבליה - lamotrigine 50 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seiaures. primary generalised tonic clonic seizures. add- on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. primary generalised tonic clonic seizures. adults ( 18 years of age and over) : lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Израиль - иврит - Ministry of Health

trima israel pharmaceutical products maabarot ltd - lamotrigine - טבליה - lamotrigine 100 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seiaures. primary generalised tonic clonic seizures. add- on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. primary generalised tonic clonic seizures. adults ( 18 years of age and over) : lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Израиль - иврит - Ministry of Health

trima israel pharmaceutical products maabarot ltd - lamotrigine - טבליה - lamotrigine 200 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seiaures. primary generalised tonic clonic seizures. add- on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. primary generalised tonic clonic seizures. adults ( 18 years of age and over) : lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Израиль - иврит - Ministry of Health

novartis israel ltd - nepafenac - תרחיף לעין - nepafenac 0.1 % - nepafenac - nepafenac - prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Израиль - иврит - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Израиль - иврит - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine